Association between decreased plasma levels of soluble human leukocyte antigen-G and severe pre-eclampsia

References

[1] Villar J, Carroli G, Wojdyla D, Abalos E, Giordano D, Ba’aqeel H, et al. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am J Obstet Gynecol. 2006;194:921–31.10.1016/j.ajog.2005.10.813Search in Google Scholar PubMed

[2] Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980–2010: age-period-cohort analysis. Br Med J. 2013;347:f6564.10.1136/bmj.f6564Search in Google Scholar PubMed PubMed Central

[3] Campbell KH, Savitz D, Werner EF, Pettker CM, Goffman D, Chazotte C, et al. Maternal morbidity and risk of death at delivery hospitalization. Obstet Gynecol. 2013;122:627–33.10.1097/AOG.0b013e3182a06f4eSearch in Google Scholar PubMed

[4] Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. Br Med J. 2007;335:974.10.1136/bmj.39335.385301.BESearch in Google Scholar PubMed PubMed Central

[5] Leeman L, Fontaine P. Hypertensive disorders of pregnancy. Am Fam Physician. 2008;78:93–100.Search in Google Scholar

[6] Saito S, Shiozaki A, Nakashima A, Sakai M, Sasaki Y. The role of the immune system in preeclampsia. Mol Aspects Med. 2007;28:192–209.10.1016/j.mam.2007.02.006Search in Google Scholar PubMed

[7] Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. Br Med J. 2005;330:565.10.1136/bmj.38380.674340.E0Search in Google Scholar PubMed PubMed Central

[8] Gallos ID, Sivakumar K, Kilby MD, Coomarasamy A, Thangaratinam S, Vatish M. Pre-eclampsia is associated with, and preceded by, hypertriglyceridaemia: a meta-analysis. BJOG. 2013;120:1321–32.10.1111/1471-0528.12375Search in Google Scholar PubMed

[9] Widmer M, Villar J, Benigni A, Conde-Agudelo A, Karumanchi SA, Lindheimer M. Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review. Obstet Gynecol. 2007;109:168–80.10.1097/01.AOG.0000249609.04831.7cSearch in Google Scholar PubMed

[10] Lim JH, Kim SY, Park SY, Yang JH, Kim MY, Ryu HM. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors. Obstet Gynecol. 2008;111:1403–9.10.1097/AOG.0b013e3181719b7aSearch in Google Scholar PubMed

[11] Nilsen RM, Bjorke-Monsen AL, Midttun O, Nygard O, Pedersen ER, Ulvik A, et al. Maternal tryptophan and kynurenine pathway metabolites and risk of preeclampsia. Obstet Gynecol. 2012;119:1243–50.10.1097/AOG.0b013e318255004eSearch in Google Scholar PubMed PubMed Central

[12] Holmes VA, Young IS, Patterson CC, Pearson DW, Walker JD, Maresh MJ, et al. Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial. Diabetes Care. 2011;34:1683–8.10.2337/dc11-0244Search in Google Scholar PubMed PubMed Central

[13] Nishizawa H, Pryor-Koishi K, Kato T, Kowa H, Kurahashi H, Udagawa Y. Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia. Placenta. 2007;28:487–97.10.1016/j.placenta.2006.05.010Search in Google Scholar PubMed

[14] Raymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv. 2011;66:497–506.10.1097/OGX.0b013e3182331028Search in Google Scholar PubMed

[15] Rizzo R, Vercammen M, van de Velde H, Horn PA, Rebmann V. The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells. Cell Mol Life Sci. 2011;68: 341–52.10.1007/s00018-010-0578-1Search in Google Scholar PubMed

[16] Guillard C, Zidi I, Marcou C, Menier C, Carosella ED, Moreau P. Role of HLA-G in innate immunity through direct activation of NF-kappaB in natural killer cells. Mol Immunol. 2008;45:419–27.10.1016/j.molimm.2007.06.160Search in Google Scholar PubMed

[17] Jiang F, Zhao H, Wang L, Guo X, Wang X, Yin G, et al. Role of HLA-G1 in trophoblast cell proliferation, adhesion and invasion. Biochem Biophys Res Commun. 2015;458:154–60.10.1016/j.bbrc.2015.01.085Search in Google Scholar PubMed

[18] Lombardelli L, Aguerre-Girr M, Logiodice F, Kullolli O, Casart Y, Polgar B, et al. HLA-G5 induces IL-4 secretion critical for successful pregnancy through differential expression of ILT2 receptor on decidual CD4(+) T cells and macrophages. J Immunol. 2013;191:3651–62.10.4049/jimmunol.1300567Search in Google Scholar PubMed

[19] Rizzo R, Andersen AS, Lassen MR, Sorensen HC, Bergholt T, Larsen MH, et al. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy. Am J Reprod Immunol. 2009;62:320–38.10.1111/j.1600-0897.2009.00742.xSearch in Google Scholar PubMed

[20] Larsen MH, Hviid TV. Human leukocyte antigen-G polymorphism in relation to expression, function, and disease. Hum Immunol. 2009;70:1026–34.10.1016/j.humimm.2009.07.015Search in Google Scholar PubMed

[21] Hunt JS, Langat DL. HLA-G: a human pregnancy-related immunomodulator. Curr Opin Pharmacol. 2009;9:462–9.10.1016/j.coph.2009.05.007Search in Google Scholar PubMed PubMed Central

[22] Apps R, Gardner L, Moffett A. A critical look at HLA-G. Trends Immunol. 2008;29:313–21.10.1016/j.it.2008.02.012Search in Google Scholar

[23] Hackmon R, Koifman A, Hyodo H, Glickman H, Sheiner E, Geraghty DE. Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia. Am J Obstet Gynecol. 2007;197:255 e251–5.10.1016/j.ajog.2007.06.033Search in Google Scholar

[24] Zhu X, Han T, Yin G, Wang X, Yao Y. Expression of human leukocyte antigen-G during normal placentation and in preeclamptic pregnancies. Hypertens Pregnancy. 2012;31:252–60.10.3109/10641955.2011.638955Search in Google Scholar

[25] Darmochwal-Kolarz D, Kolarz B, Rolinski J, Leszczynska-Gorzelak B, Oleszczuk J. The concentrations of soluble HLA-G protein are elevated during mid-gestation and decreased in pre-eclampsia. Folia Histochem Cytobiol. 2012;50:286–91.10.5603/FHC.2012.0023Search in Google Scholar

[26] Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376:631–44.10.1016/S0140-6736(10)60279-6Search in Google Scholar

[27] Rebmann V, LeMaoult J, Rouas-Freiss N, Carosella ED, Grosse-Wilde H. Quantification and identification of soluble HLA-G isoforms. Tissue Antigens. 2007;69:143–9.10.1111/j.1399-0039.2006.763_5.xSearch in Google Scholar

[28] Rebmann V, Lemaoult J, Rouas-Freiss N, Carosella ED, Grosse-Wilde H. Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004. Hum Immunol. 2005;66: 853–63.10.1016/j.humimm.2005.05.003Search in Google Scholar

[29] Khatun S, Kanayama N, Belayet HM, Bhuiyan AB, Jahan S, Begum A, et al. Increased concentrations of plasma neuropeptide Y in patients with eclampsia and preeclampsia. Am J Obstet Gynecol. 2000;182:896–900.10.1016/S0002-9378(00)70342-5Search in Google Scholar

[30] Alegre E, Diaz-Lagares A, Lemaoult J, Lopez-Moratalla N, Carosella ED, Gonzalez A. Maternal antigen presenting cells are a source of plasmatic HLA-G during pregnancy: longitudinal study during pregnancy. Hum Immunol. 2007;68:661–7.10.1016/j.humimm.2007.04.007Search in Google Scholar PubMed

[31] Yie SM, Li LH, Li YM, Librach C. HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia. Am J Obstet Gynecol. 2004;191:525–9.10.1016/j.ajog.2004.01.033Search in Google Scholar PubMed

[32] Klitkou L, Dahl M, Hviid TV, Djurisic S, Piosik ZM, Skovbo P, et al. Human leukocyte antigen (HLA)-G during pregnancy part I: correlations between maternal soluble HLA-G at midterm, at term, and umbilical cord blood soluble HLA-G at term. Hum Immunol. 2015;76:254–9.10.1016/j.humimm.2015.01.013Search in Google Scholar PubMed

[33] Djurisic S, Hviid TV. HLA class Ib molecules and immune cells in pregnancy and preeclampsia. Front Immunol. 2014;5:652.10.3389/fimmu.2014.00652Search in Google Scholar PubMed PubMed Central

[34] Biyik I. Maternal serum soluble HLA-G in complicated pregnancies. J Matern Fetal Neonatal Med. 2014;27:381–4.10.3109/14767058.2013.818126Search in Google Scholar PubMed

[35] Hackmon R, Hallak M, Krup M, Weitzman D, Sheiner E, Kaplan B, et al. HLA-G antigen and parturition: maternal serum, fetal serum and amniotic fluid levels during pregnancy. Fetal Diagn Ther. 2004;19:404–9.10.1159/000078992Search in Google Scholar PubMed

[36] Steinborn A, Varkonyi T, Scharf A, Bahlmann F, Klee A, Sohn C. Early detection of decreased soluble HLA-G levels in the maternal circulation predicts the occurrence of preeclampsia and intrauterine growth retardation during further course of pregnancy. Am J Reprod Immunol. 2007;57:277–86.10.1111/j.1600-0897.2007.00475.xSearch in Google Scholar PubMed

[37] Ishitani A, Sageshima N, Hatake K. The involvement of HLA-E and -F in pregnancy. J Reprod Immunol. 2006;69:101–13.10.1016/j.jri.2005.10.004Search in Google Scholar PubMed

[38] Shobu T, Sageshima N, Tokui H, Omura M, Saito K, Nagatsuka Y, et al. The surface expression of HLA-F on decidual trophoblasts increases from mid to term gestation. J Reprod Immunol. 2006;72:18–32.10.1016/j.jri.2006.02.001Search in Google Scholar PubMed

[39] Bhalla A, Stone PR, Liddell HS, Zanderigo A, Chamley LW. Comparison of the expression of human leukocyte antigen (HLA)-G and HLA-E in women with normal pregnancy and those with recurrent miscarriage. Reproduction. 2006;131:583–9.10.1530/rep.1.00892Search in Google Scholar PubMed

[40] LaMarca BD, Gilbert J, Granger JP. Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia. Hypertension. 2008;51:982–8.10.1161/HYPERTENSIONAHA.107.108837Search in Google Scholar PubMed PubMed Central

[41] Brosens JJ, Pijnenborg R, Brosens IA. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am J Obstet Gynecol. 2002;187:1416–23.10.1067/mob.2002.127305Search in Google Scholar PubMed